Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases

被引:20
|
作者
Swaddiwudhipong, Nol [1 ,2 ]
Whiteside, David J. [1 ,2 ]
Hezemans, Frank H. [1 ,3 ]
Street, Duncan [1 ]
Rowe, James B. [1 ,2 ,3 ]
Rittman, Timothy [1 ,2 ]
机构
[1] Dept Clin Neurosci, Herchel Smith Bldg,Robinson Way, Cambridge CB2 0SZ, England
[2] Univ Cambridge, Cambridge Univ Hosp NHS Trust, Cambridge, England
[3] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England
关键词
Alzheimer's disease; cognition; dementia; dementia with Lewy bodies; frontotemporal dementia; multiple system atrophy; neurodegenerative disease; Parkinson disease; physical function; pre-diagnostic; progressive supranuclear palsy; sporadic; UK Biobank; FALSE DISCOVERY RATE; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; SYSTEM ATROPHY; R PACKAGE; DIAGNOSIS; BETA; TAU;
D O I
10.1002/alz.12802
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The pathophysiological processes of neurodegenerative diseases begin years before diagnosis. However, pre-diagnostic changes in cognition and physical function are poorly understood, especially in sporadic neurodegenerative disease. Methods UK Biobank data were extracted. Cognitive and functional measures in individuals who subsequently developed Alzheimer's disease (AD), Parkinson disease, frontotemporal dementia, progressive supranuclear palsy, dementia with Lewy bodies, or multiple system atrophy were compared against individuals without neurodegenerative diagnoses. The same measures were regressed against time to diagnosis, after adjusting for the effects of age. Results There was evidence for pre-diagnostic cognitive impairment and decline with time, particularly in AD. Pre-diagnostic functional impairment and decline were observed in multiple diseases. Discussion The scale and longitudinal follow-up of UK Biobank participants provides evidence for cognitive and functional decline years before symptoms become obvious in multiple neurodegenerative diseases. Identifying pre-diagnostic functional and cognitive changes could improve selection for preventive and early disease-modifying treatment trials.
引用
收藏
页码:1752 / 1763
页数:12
相关论文
共 50 条
  • [21] Normal and Abnormal Stage N3 Sleep in Patients with Cognitive Impairment and/or Neurodegenerative Diseases
    Levendowski, Daniel
    Boeve, Bradley
    Shprecher, David
    Lee-Iannotti, Joyce
    Salat, David
    Hamilton, Joanne
    Neylan, Thomas
    Walsh, Christine
    Tsuang, Debby
    Westbrook, Philip
    Berka, Chris
    Mazeika, Gandis
    Angel, Elise
    St Louis, Erik
    NEUROLOGY, 2021, 96 (15)
  • [22] Probing neurophysiological vigilance systems in neurodegenerative diseases with cognitive impairment: resting state EEG biomarkers
    Babiloni, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 25 - 25
  • [23] Structural and Functional Connectivity Substrates of Cognitive Impairment in Multiple Sclerosis
    Zhang, Jian
    Cortese, Rosa
    De Stefano, Nicola
    Giorgio, Antonio
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [24] Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis
    D'Ambrosio, Alessandro
    Valsasina, Paola
    Gallo, Antonio
    De Stefano, Nicola
    Pareto, Deborah
    Barkhof, Frederik
    Ciccarelli, Olga
    Enzinger, Christian
    Tedeschi, Gioacchino
    Stromillo, M. Laura
    Arevalo, Maria J.
    Hulst, Hanneke E.
    Muhlert, Nils
    Koini, Marisa
    Filippi, Massimo
    Rocca, Maria A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (04) : 476 - 488
  • [25] Screening hospitalized injured older adults for cognitive impairment and pre-injury functional impairment
    Maxwell, Cathy A.
    APPLIED NURSING RESEARCH, 2013, 26 (03) : 146 - 150
  • [26] Comparison of pre-existing cognitive impairment, amnesic mild cognitive impairment, and multiple domain mild cognitive impairment in men scheduled for coronary artery surgery
    Hudetz, Judith A.
    Patterson, Kathleen M.
    Pagel, Paul S.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2012, 29 (07) : 320 - 325
  • [27] Toxicity mechanisms of arsenic that are shared with neurodegenerative diseases and cognitive impairment: Role of oxidative stress and inflammatory responses
    Escudero-Lourdes, Claudia
    NEUROTOXICOLOGY, 2016, 53 : 223 - 235
  • [28] Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases
    Li, Peng
    Zheng, Hailin
    Zhao, Jun
    Zhang, Lei
    Yao, Wei
    Zhu, Hongwen
    Beard, J. David
    Ida, Koh
    Lane, Weston
    Snell, Gyorgy
    Sogabe, Satoshi
    Heyser, Charles J.
    Snyder, Gretchen L.
    Hendrick, Joseph P.
    Vanover, Kimberly E.
    Davis, Robert E.
    Wennogle, Lawrence P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (03) : 1149 - 1164
  • [29] Cognitive Impairment in Multiple Sclerosis: A Multiparametric Structural and Functional MRI Study
    Vizzino, C.
    Riccitelli, G. C.
    Pagani, E.
    Valsasina, P.
    Preziosa, P.
    Marchesi, O.
    Filippi, M.
    Rocca, M. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 434 - 434
  • [30] Increased functional connectivity indicates the severity of cognitive impairment in multiple sclerosis
    Hawellek, David J.
    Hipp, Joerg F.
    Lewis, Christopher M.
    Corbetta, Maurizio
    Engel, Andreas K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (47) : 19066 - 19071